Applied Research Associates, Inc. Acquires Berrie Hill Research Corporation
Jun 01, 2017 11:13 am UTC| Business
Albuquerque, NM, June 01, 2017 -- Applied Research Associates, Inc. (ARA), an employee-owned scientific research and engineering company, has today announced the acquisition of Berrie Hill Research Corporation (BRC),...
Applied Research Associates, Inc. Acquires Berrie Hill Research Corporation
Jun 01, 2017 11:13 am UTC| Business
Albuquerque, NM, June 01, 2017 -- Applied Research Associates, Inc. (ARA), an employee-owned scientific research and engineering company, has today announced the acquisition of Berrie Hill Research Corporation (BRC),...
Applied Research Associates, Inc. Acquires Berrie Hill Research Corporation
Jun 01, 2017 11:13 am UTC| Business
Albuquerque, NM, June 01, 2017 -- Applied Research Associates, Inc. (ARA), an employee-owned scientific research and engineering company, has today announced the acquisition of Berrie Hill Research Corporation (BRC),...
Applied Research Associates, Inc. Acquires Berrie Hill Research Corporation
Jun 01, 2017 11:13 am UTC| Business
Albuquerque, NM, June 01, 2017 -- Applied Research Associates, Inc. (ARA), an employee-owned scientific research and engineering company, has today announced the acquisition of Berrie Hill Research Corporation (BRC),...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Leap Therapeutics to Present at Two Investor Conferences in June
Jun 01, 2017 11:12 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows